Not all inflammatory markers are linked to kidney function: Results from a population-based study

American Journal of Nephrology

Volumn 35, Issue 3, 2012, Pages 288-294

  Pruijm, Menno ^a   Ponte, Belén ^c   Vollenweider, Peter ^a   Mooser, Vincent ^a   Paccaud, Fred ^b   Waeber, Gérard ^a   Marques Vidal, Pedro ^b   Burnier, Michel ^a   Bochud, Murielle ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Biomarkers; C reactive protein; Chronic kidney disease; Interleukin 1 ; Interleukin 6; Microalbuminuria; Tumor necrosis factor

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD LEVEL; BODY MASS; CAUCASIAN; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEX; SMOKING; SWITZERLAND;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; KIDNEY; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857763963     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000335934     Document Type: Article

References (25)

1. Glassock RJ: The rising tide of end-stage renal disease: what can be done? Clin Exp Nephrol 2004;8:291-296.
2. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505-521.
3. Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O'Donnell CJ, Kathiresan S, Meigs JB, Keaney JF Jr, Rong J, Benjamin EJ, Fox CS: Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant 2011;26:920-926.
4. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107:87-92. (Pubitemid 36070938)
5. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 2004;15:3184-3191. (Pubitemid 39578851)
6. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007;71:239-244. (Pubitemid 46160924)
7. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G: Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005;68:237-245. (Pubitemid 43181381)
8. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, de Jong PE, de ZD: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003;63:654-661. (Pubitemid 36126812)
9. Keller C, Katz R, Cushman M, Fried LF, Shlipak M: Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol 2008;9:9.
10. Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P: The CoLaus Study: a populationbased study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008;8:6.
11. Marques-Vidal P, Bochud M, Bastardot F, Luscher T, Ferrero F, Gaspoz JM, Paccaud F, Urwyler A, von Känel R, Hock C, Waeber G, Preisig M, Vollenweider P: Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus Study). PLoS One 2011;6:e21002.
12. Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002;13:1034-1039. (Pubitemid 34274100)
13. Glass DC, Gray CN: Estimating mean exposures from censored data: exposure to benzene in the Australian petroleum industry. Ann Occup Hyg 2001;45:275-282.
14. Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, Peters JR: Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992;41:829-835.
15. Keller C, Katz R, Sarnak MJ, Fried LF, Kesten baum B, Cushman M, Shlipak MG: Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant 2010;25:119-124.
16. Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS: Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 2002;62:2208-2215. (Pubitemid 35366177)
17. Bautista LE, Vera LM, Arenas IA, Gamarra G: Independent association between inflammatory markers (C-reactive protein, interleukin- 6, and TNF-α) and essential hypertension. J Hum Hypertens 2005;19:149-154. (Pubitemid 40220638)
18. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C: Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens 2004;17:568-573. (Pubitemid 38844982)
19. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G: Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 1989;134:419-430. (Pubitemid 19063898)
20. Glassock RJ: Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep 2010;12:364-368.
21. Navarro JF, Mora C, Maca M, Garca J: Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 2003;42:53-61. (Pubitemid 36807654)
22. Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, Segawa T, Sasaki J, Tonari Y, Hiramori K, Okayama A: Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 2004;43:919-925. (Pubitemid 39534794)
23. Dubin R, Shlipak M, Li Y, Ix J, de Boer IH, Jenny N, Peralta CA: Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant 2011; 26: 1903-1908.
24. Wisse BE: The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792-2800.
25. Rudberg S, Persson B, Dahlquist G: Increased glomerular filtration rate as a predictor of diabetic nephropathy - an 8-year prospective study. Kidney Int 1992;41:822-828.